Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Peijia Medical Ltd. ( (HK:9996) ) just unveiled an update.
Peijia Medical Limited has called its annual general meeting for May 29, 2026 in Suzhou, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the year ended December 31, 2025. The agenda also includes re-election of four retiring directors, authorization for the board to set director and auditor remuneration, appointment of Deloitte Touche Tohmatsu as auditor for the coming year, and approval of a general mandate allowing the board to issue up to 20% of the existing share capital, excluding treasury shares.
These resolutions, if approved, will refresh Peijia Medical’s corporate governance mandates and provide management with flexibility to raise equity capital or pursue strategic initiatives through new share issuance. The combination of director re-elections, external auditor appointment, and an expanded share allotment mandate is likely to shape the company’s financial management, capital structure options, and oversight framework over the next financial year, with implications for existing shareholders’ potential dilution and the company’s capacity to fund growth.
More about Peijia Medical Ltd.
Peijia Medical Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the medical devices and healthcare sector. The group develops and commercializes medical products through its subsidiaries, serving patients and healthcare providers in mainland China and potentially other markets in the region.
Average Trading Volume: 1,054,291
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.7B
Learn more about 9996 stock on TipRanks’ Stock Analysis page.